Anteris Technologies
   HOME

TheInfoList



OR:

Anteris Technologies Limited is an Australian biotechnology company.


History

Anteris originates from the merger of Allied Medical and BioMD. Allied Medical was a company spun out of mining company
Fortescue Metals Group Fortescue is a global metal mining company headquartered in Australia. Fortescue focused on iron ore mining under the name of Fortescue Metals Group (FMG) until July 2023. As of 2017, Fortescue is the fourth-largest iron ore producer in the ...
in 2005 which focused on selling medical equipment such as
catheter In medicine, a catheter ( ) is a thin tubing (material), tube made from medical grade materials serving a broad range of functions. Catheters are medical devices that can be inserted in the body to treat diseases or perform a surgical procedure. ...
s. It entered the biotechnology space in July 2010 when it purchased a 38.6 per cent stake in
Brisbane Brisbane ( ; ) is the List of Australian capital cities, capital and largest city of the States and territories of Australia, state of Queensland and the list of cities in Australia by population, third-most populous city in Australia, with a ...
-based Coridon for A$3 million. By February 2011, its stake increased to 55 per cent. In February 2011, Allied Medical agreed to a
reverse takeover A reverse takeover (RTO), reverse merger, or reverse IPO is the acquisition of a public company by a private company so that the private company can bypass the lengthy and complex process of going public. Sometimes, conversely, the public compa ...
deal with BioMD, a listed biotech company. The takeover was completed in June 2011 resulting in the combined company, Allied Healthcare Group, listing on the
Australian Securities Exchange Australian Securities Exchange Ltd (ASX) is an Australian public company that operates Australia's primary Exchange (organized market), securities exchange, the Australian Securities Exchange (sometimes referred to outside of Australia as, or c ...
(ASX). In September 2012, Allied raised $10.4 million to launch CardioCel across Europe. In November 2013, Allied Healthcare changed its name to ''Admedus''. In December 2013, Admedus purchased a manufacturing site in Malaga to scale-up production of CardioCel and support the development and manufacture of additional regenerative tissue products. In October 2019, Admedus sold its CardioCel and VascuCel patch business to U.S.-based
LeMaitre Vascular LeMaitre Vascular is an American medical device company established in 1986 by vascular surgeon George D. LeMaitre, and based in Burlington, Massachusetts,Joyce Pellino Crane, "Surgeon's idea and persistence gave rise to $30.5m company", ''The Bo ...
. Under the agreement, Admedus received A$22.8 million upfront followed by deferred payments of $1 million each at 12 months and at 36 months. Additionally, the company could receive up to $11.4 million in earn-out payments. Admedus retained the right to manufacture CardioCel and VascuCel products at its Malaga facility for LeMaitre over the following three years. In May 2020, Admedus changed its name to ''Anteris Technologies''.


References


External links

* {{DEFAULTSORT:Anteris Technologies Biotechnology companies of Australia Companies based in Brisbane Health care companies of Australia Companies listed on the Australian Securities Exchange